|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-6-18
|
|
pubmed:abstractText |
To assess the rate of objective response to pegylated liposomal doxorubicin hydrochloride (Caelyx) in patients with advanced or refractory cutaneous T-cell lymphoma (CTCL).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1538-3652
|
|
pubmed:author |
pubmed-author:BedaneChristopheC,
pubmed-author:Beylot-BarryMarieM,
pubmed-author:CelerierPhilippeP,
pubmed-author:ClaudyAlainA,
pubmed-author:D'incanMichelM,
pubmed-author:DelaunayMicheleM,
pubmed-author:DereureOlivierO,
pubmed-author:DrenoBrigitteB,
pubmed-author:GrangeFlorentF,
pubmed-author:JolyPascalP,
pubmed-author:KhammariAmirA,
pubmed-author:MarquesSoniaS,
pubmed-author:MartinLudovicL,
pubmed-author:NguyenJean-MichelJM,
pubmed-author:PuzenatElisabethE,
pubmed-author:QuereuxGaëlleG,
pubmed-author:SasolasBrunoB,
pubmed-author:VabresPierreP
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
144
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
727-33
|
|
pubmed:meshHeading |
pubmed-meshheading:18559761-Adult,
pubmed-meshheading:18559761-Aged,
pubmed-meshheading:18559761-Dose-Response Relationship, Drug,
pubmed-meshheading:18559761-Doxorubicin,
pubmed-meshheading:18559761-Female,
pubmed-meshheading:18559761-Follow-Up Studies,
pubmed-meshheading:18559761-Humans,
pubmed-meshheading:18559761-Injections, Intravenous,
pubmed-meshheading:18559761-Male,
pubmed-meshheading:18559761-Middle Aged,
pubmed-meshheading:18559761-Mycosis Fungoides,
pubmed-meshheading:18559761-Neoplasm Staging,
pubmed-meshheading:18559761-Polyethylene Glycols,
pubmed-meshheading:18559761-Prospective Studies,
pubmed-meshheading:18559761-Skin Neoplasms,
pubmed-meshheading:18559761-Syndrome,
pubmed-meshheading:18559761-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with advanced or refractory mycosis fungoides or Sézary syndrome.
|
|
pubmed:affiliation |
Departments of Dermatology, Centre Hospitalier Universitaire, Nantes, France.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
